| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.00e-06 | 6 | 94 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.00e-06 | 6 | 94 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 5.56e-06 | 8 | 94 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 8.31e-06 | 9 | 94 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 2.79e-05 | 13 | 94 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 5.41e-05 | 16 | 94 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 6.55e-05 | 17 | 94 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.83e-05 | 18 | 94 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.09e-04 | 20 | 94 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.67e-04 | 23 | 94 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | ATP-activated inward rectifier potassium channel activity | 3.25e-04 | 6 | 94 | 2 | GO:0015272 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.33e-04 | 70 | 94 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 5.25e-04 | 140 | 94 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | TMEM94 ABCC8 DDX25 MLH1 KIF14 KIFC3 KATNA1 DHX29 DNAH14 KIF25 | 6.24e-04 | 614 | 94 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule binding | 6.32e-04 | 308 | 94 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.09e-03 | 43 | 94 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.28e-03 | 100 | 94 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.19e-03 | 193 | 94 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.35e-03 | 118 | 94 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.40e-03 | 197 | 94 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.46e-03 | 57 | 94 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.85e-03 | 60 | 94 | 3 | GO:0099529 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 5.05e-06 | 8 | 94 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.07e-05 | 10 | 94 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.07e-05 | 10 | 94 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 1.47e-05 | 11 | 94 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 1.96e-05 | 12 | 94 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 2.38e-05 | 37 | 94 | 4 | GO:0042219 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 4.92e-05 | 16 | 94 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | A2M FSIP2 NCOR2 PDE4D POC1A ALMS1 DSG1 NOX5 BSG GGTLC1 DDX25 MLH1 ROS1 GGTLC2 CTSB GGT3P | 9.17e-05 | 1194 | 94 | 16 | GO:0048609 |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 9.88e-05 | 20 | 94 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.15e-04 | 21 | 94 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 1.33e-04 | 22 | 94 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 1.33e-04 | 22 | 94 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.70e-04 | 179 | 94 | 6 | GO:0031023 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 1.96e-04 | 25 | 94 | 3 | GO:0009070 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 6.84e-05 | 18 | 94 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | microtubule associated complex | 8.85e-05 | 161 | 94 | 6 | GO:0005875 | |
| MousePheno | abnormal circulating glutathione level | 1.47e-06 | 5 | 75 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.47e-06 | 5 | 75 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 1.47e-06 | 5 | 75 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 1.47e-06 | 5 | 75 | 3 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 5.11e-06 | 7 | 75 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 8.15e-06 | 8 | 75 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 8.15e-06 | 8 | 75 | 3 | MP:0004932 | |
| MousePheno | nervous | 1.22e-05 | 9 | 75 | 3 | MP:0008912 | |
| MousePheno | abnormal epididymis morphology | 1.31e-05 | 269 | 75 | 9 | MP:0002631 | |
| MousePheno | failure of copulatory plug deposition | 1.73e-05 | 10 | 75 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 1.73e-05 | 10 | 75 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 1.73e-05 | 10 | 75 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 2.37e-05 | 11 | 75 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 2.37e-05 | 11 | 75 | 3 | MP:0011130 | |
| MousePheno | abnormal cysteine level | 4.08e-05 | 13 | 75 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 4.08e-05 | 13 | 75 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 4.08e-05 | 13 | 75 | 3 | MP:0012603 | |
| MousePheno | abnormal thyroid hormone level | 4.69e-05 | 74 | 75 | 5 | MP:0005468 | |
| MousePheno | abnormal amino acid level | MAGI2 DSG1 KCNJ10 GGTLC1 ZNF205 CPD PNPLA7 GGTLC2 PDGFC DCTN1 GBA2 GGT3P | 4.69e-05 | 570 | 75 | 12 | MP:0005332 |
| MousePheno | abnormal circulating amino acid level | MAGI2 DSG1 GGTLC1 ZNF205 CPD PNPLA7 GGTLC2 PDGFC DCTN1 GBA2 GGT3P | 4.78e-05 | 481 | 75 | 11 | MP:0005311 |
| MousePheno | priapism | 5.17e-05 | 14 | 75 | 3 | MP:0003415 | |
| MousePheno | abnormal copulatory plug deposition | 7.90e-05 | 16 | 75 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 7.90e-05 | 16 | 75 | 3 | MP:0008477 | |
| MousePheno | decreased long bone epiphyseal plate size | 8.82e-05 | 44 | 75 | 4 | MP:0006396 | |
| MousePheno | failure of superovulation | 1.14e-04 | 18 | 75 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.14e-04 | 18 | 75 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.14e-04 | 18 | 75 | 3 | MP:0009093 | |
| MousePheno | increased circulating growth hormone level | 1.35e-04 | 19 | 75 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 1.35e-04 | 19 | 75 | 3 | MP:0031627 | |
| MousePheno | decreased thyroxine level | 1.58e-04 | 51 | 75 | 4 | MP:0005471 | |
| MousePheno | abnormal axial skeleton morphology | FBLN1 BRINP3 CELSR1 PIGA POC1A TMEM94 MYOG GGTLC1 RLIM HIPK2 ZFHX2 PNPLA7 GGTLC2 WLS PDGFC TRIP11 CHRNA1 MNT GGT3P | 1.87e-04 | 1458 | 75 | 19 | MP:0002114 |
| MousePheno | small vertebrae | 2.12e-04 | 22 | 75 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 2.43e-04 | 23 | 75 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 2.43e-04 | 23 | 75 | 3 | MP:0001121 | |
| MousePheno | disproportionate dwarf | 2.43e-04 | 57 | 75 | 4 | MP:0002427 | |
| MousePheno | abnormal vertebral column morphology | FBLN1 BRINP3 POC1A MYOG GGTLC1 RLIM ZFHX2 PNPLA7 GGTLC2 WLS PDGFC CHRNA1 GGT3P | 2.55e-04 | 787 | 75 | 13 | MP:0004703 |
| MousePheno | abnormal copulation behavior | 2.77e-04 | 24 | 75 | 3 | MP:0009697 | |
| MousePheno | abnormal urine amino acid level | 2.78e-04 | 59 | 75 | 4 | MP:0011468 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 3.16e-04 | 61 | 75 | 4 | MP:0004701 | |
| MousePheno | abnormal internal male genitalia morphology | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 ZFHX2 ROS1 GGTLC2 KATNA1 PDGFC GBA2 CHRNB2 GGT3P | 3.17e-04 | 1392 | 75 | 18 | MP:0009205 |
| MousePheno | nuclear cataract | 3.53e-04 | 26 | 75 | 3 | MP:0010254 | |
| MousePheno | abnormal male genitalia morphology | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 ZFHX2 ROS1 GGTLC2 KATNA1 PDGFC GBA2 CHRNB2 GGT3P | 3.88e-04 | 1415 | 75 | 18 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 ZFHX2 ROS1 GGTLC2 KATNA1 PDGFC GBA2 CHRNB2 GGT3P | 3.88e-04 | 1415 | 75 | 18 | MP:0001145 |
| MousePheno | abnormal superovulation | 4.28e-04 | 66 | 75 | 4 | MP:0009648 | |
| MousePheno | abnormal thyroxine level | 4.28e-04 | 66 | 75 | 4 | MP:0005469 | |
| MousePheno | paralysis | 4.41e-04 | 119 | 75 | 5 | MP:0000753 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 4.80e-04 | 68 | 75 | 4 | MP:0003662 | |
| MousePheno | aminoaciduria | 4.90e-04 | 29 | 75 | 3 | MP:0003311 | |
| MousePheno | decreased circulating amino acid level | 4.95e-04 | 187 | 75 | 6 | MP:0014531 | |
| MousePheno | increased mechanical nociceptive threshold | 5.86e-04 | 7 | 75 | 2 | MP:0020955 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 5.97e-04 | 72 | 75 | 4 | MP:0004700 | |
| MousePheno | abnormal insulin-like growth factor I level | 6.96e-04 | 75 | 75 | 4 | MP:0008831 | |
| MousePheno | anovulation | 7.21e-04 | 33 | 75 | 3 | MP:0008869 | |
| MousePheno | increased osteoclast cell number | 7.69e-04 | 77 | 75 | 4 | MP:0004984 | |
| MousePheno | small gonad | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 GGTLC2 GBA2 GGT3P | 7.81e-04 | 885 | 75 | 13 | MP:0001116 |
| MousePheno | decreased circulating follicle stimulating hormone level | 7.88e-04 | 34 | 75 | 3 | MP:0002790 | |
| MousePheno | abnormal urine homeostasis | 8.39e-04 | 466 | 75 | 9 | MP:0009643 | |
| MousePheno | hindlimb paralysis | 8.47e-04 | 79 | 75 | 4 | MP:0000755 | |
| MousePheno | abnormal primary sex determination | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 GGTLC2 GBA2 GGT3P | 9.22e-04 | 901 | 75 | 13 | MP:0002211 |
| MousePheno | limb paralysis | 1.02e-03 | 83 | 75 | 4 | MP:0013147 | |
| MousePheno | decreased circulating estradiol level | 1.09e-03 | 38 | 75 | 3 | MP:0005181 | |
| MousePheno | decreased tertiary ovarian follicle number | 1.18e-03 | 39 | 75 | 3 | MP:0011129 | |
| MousePheno | decreased circulating estrogen level | 1.37e-03 | 41 | 75 | 3 | MP:0003371 | |
| MousePheno | kyphosis | 1.42e-03 | 229 | 75 | 6 | MP:0000160 | |
| MousePheno | abnormal sex determination | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 GGTLC2 GBA2 GGT3P | 1.43e-03 | 945 | 75 | 13 | MP:0002210 |
| MousePheno | decreased body temperature | 1.44e-03 | 91 | 75 | 4 | MP:0005534 | |
| MousePheno | induced hyperactivity | 1.47e-03 | 42 | 75 | 3 | MP:0008911 | |
| MousePheno | abnormal spine curvature | 1.56e-03 | 318 | 75 | 7 | MP:0004174 | |
| MousePheno | abnormal testis morphology | GREB1L RAD51AP2 CELSR1 POC1A ALMS1 CLASP1 BSG GGTLC1 DDX25 MLH1 GGTLC2 KATNA1 GBA2 GGT3P | 1.63e-03 | 1081 | 75 | 14 | MP:0001146 |
| MousePheno | decreased follicle stimulating hormone level | 1.68e-03 | 44 | 75 | 3 | MP:0005130 | |
| MousePheno | absent estrous cycle | 1.68e-03 | 44 | 75 | 3 | MP:0009009 | |
| MousePheno | decreased amino acid level | 1.82e-03 | 97 | 75 | 4 | MP:0014528 | |
| MousePheno | abnormal ovulation | 1.82e-03 | 97 | 75 | 4 | MP:0001928 | |
| MousePheno | abnormal reproductive system development | 1.96e-03 | 99 | 75 | 4 | MP:0003936 | |
| MousePheno | abnormal epididymis size | 1.96e-03 | 166 | 75 | 5 | MP:0004926 | |
| MousePheno | abnormal tertiary ovarian follicle number | 2.03e-03 | 47 | 75 | 3 | MP:0011127 | |
| MousePheno | abnormal cartilage morphology | 2.13e-03 | 336 | 75 | 7 | MP:0000163 | |
| Domain | GGT_peptidase | 3.99e-06 | 7 | 92 | 3 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 3.99e-06 | 7 | 92 | 3 | PS00462 | |
| Domain | G_glu_transpept | 3.99e-06 | 7 | 92 | 3 | PF01019 | |
| Domain | Nicotinic_acetylcholine_rcpt | 6.18e-05 | 16 | 92 | 3 | IPR002394 | |
| Domain | - | 1.91e-04 | 23 | 92 | 3 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 1.91e-04 | 23 | 92 | 3 | IPR027361 | |
| Domain | ANATO | 4.96e-04 | 7 | 92 | 2 | SM00104 | |
| Domain | ANATO | 4.96e-04 | 7 | 92 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 4.96e-04 | 7 | 92 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 4.96e-04 | 7 | 92 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 4.96e-04 | 7 | 92 | 2 | IPR000020 | |
| Domain | A2M_N_2 | 6.59e-04 | 8 | 92 | 2 | SM01359 | |
| Domain | - | 6.59e-04 | 8 | 92 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 6.59e-04 | 8 | 92 | 2 | SM01361 | |
| Domain | A2M | 6.59e-04 | 8 | 92 | 2 | SM01360 | |
| Domain | A2M_N | 1.05e-03 | 10 | 92 | 2 | PF01835 | |
| Domain | A2M_N | 1.05e-03 | 10 | 92 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.05e-03 | 10 | 92 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.05e-03 | 10 | 92 | 2 | PS00477 | |
| Domain | A2M | 1.05e-03 | 10 | 92 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.05e-03 | 10 | 92 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.05e-03 | 10 | 92 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.05e-03 | 10 | 92 | 2 | PF07703 | |
| Domain | A2M_recep | 1.05e-03 | 10 | 92 | 2 | PF07677 | |
| Domain | A2M_comp | 1.05e-03 | 10 | 92 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.05e-03 | 10 | 92 | 2 | IPR001599 | |
| Domain | Kinesin_motor_CS | 1.08e-03 | 41 | 92 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.24e-03 | 43 | 92 | 3 | IPR027640 | |
| Domain | - | 1.29e-03 | 333 | 92 | 7 | 2.130.10.10 | |
| Domain | KINESIN_MOTOR_1 | 1.32e-03 | 44 | 92 | 3 | PS00411 | |
| Domain | - | 1.32e-03 | 44 | 92 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.32e-03 | 44 | 92 | 3 | IPR001752 | |
| Domain | Kinesin | 1.32e-03 | 44 | 92 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.32e-03 | 44 | 92 | 3 | PS50067 | |
| Domain | KISc | 1.32e-03 | 44 | 92 | 3 | SM00129 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.33e-03 | 335 | 92 | 7 | IPR015943 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.41e-03 | 45 | 92 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.51e-03 | 46 | 92 | 3 | PF02932 | |
| Domain | - | 1.53e-03 | 12 | 92 | 2 | 1.50.10.20 | |
| Domain | Neur_chan_LBD | 1.60e-03 | 47 | 92 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.60e-03 | 47 | 92 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.60e-03 | 47 | 92 | 3 | IPR006029 | |
| Domain | - | 1.60e-03 | 47 | 92 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 1.60e-03 | 47 | 92 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.60e-03 | 47 | 92 | 3 | IPR006202 | |
| Domain | Ig_E-set | 1.74e-03 | 104 | 92 | 4 | IPR014756 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.27e-03 | 53 | 92 | 3 | IPR011047 | |
| Domain | - | 2.42e-03 | 15 | 92 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 2.42e-03 | 15 | 92 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 2.42e-03 | 15 | 92 | 2 | IPR023394 | |
| Domain | Sec7 | 2.75e-03 | 16 | 92 | 2 | SM00222 | |
| Domain | SEC7 | 2.75e-03 | 16 | 92 | 2 | PS50190 | |
| Domain | Sec7_dom | 2.75e-03 | 16 | 92 | 2 | IPR000904 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.49e-03 | 18 | 92 | 2 | IPR008930 | |
| Domain | WD40_repeat_dom | 3.49e-03 | 297 | 92 | 6 | IPR017986 | |
| Domain | Apc4_WD40_dom | 4.30e-03 | 20 | 92 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.30e-03 | 20 | 92 | 2 | PF12894 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.05e-05 | 9 | 72 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.05e-05 | 9 | 72 | 3 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.05e-05 | 11 | 72 | 3 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.72e-05 | 12 | 72 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.72e-05 | 12 | 72 | 3 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 4.47e-05 | 14 | 72 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 5.56e-05 | 15 | 72 | 3 | MM14704 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 6.82e-05 | 16 | 72 | 3 | MM14680 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.83e-04 | 22 | 72 | 3 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 2.39e-04 | 24 | 72 | 3 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.71e-04 | 25 | 72 | 3 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 3.05e-04 | 26 | 72 | 3 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 3.42e-04 | 27 | 72 | 3 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 6.24e-04 | 33 | 72 | 3 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 7.44e-04 | 35 | 72 | 3 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 9.48e-04 | 38 | 72 | 3 | MM14600 | |
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 1.90e-07 | 5 | 94 | 3 | 18063838 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 1.90e-07 | 5 | 94 | 3 | 11095909 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 7641802 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 23615310 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 9627710 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 12453183 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 11003618 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 10392451 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 2891746 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 1.90e-07 | 5 | 94 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 1.90e-07 | 5 | 94 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 1.90e-07 | 5 | 94 | 3 | 11089562 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 1.90e-07 | 5 | 94 | 3 | 12468440 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 1.90e-07 | 5 | 94 | 3 | 12225953 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 7775425 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 1.90e-07 | 5 | 94 | 3 | 8566783 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 30591459 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 9139708 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 1.90e-07 | 5 | 94 | 3 | 9546365 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 11795900 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 1.90e-07 | 5 | 94 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 1.90e-07 | 5 | 94 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 1.90e-07 | 5 | 94 | 3 | 24698228 | |
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 1.90e-07 | 5 | 94 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 1.90e-07 | 5 | 94 | 3 | 19760322 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 10474818 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 14634009 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 3.80e-07 | 6 | 94 | 3 | 8101000 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 3.80e-07 | 6 | 94 | 3 | 8104871 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 11463821 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 25326709 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 12163373 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 22242126 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 27775020 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 6.64e-07 | 7 | 94 | 3 | 32284594 | |
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 6.64e-07 | 7 | 94 | 3 | 1968405 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 36685533 | ||
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 23863468 | ||
| Pubmed | MAGI2 FLNC IQSEC3 PDE4D UPF2 CLASP1 DPYSL5 GEMIN5 SRCIN1 BCAS1 XPO1 DCTN1 TRIP11 DHX29 ELFN2 | 6.67e-06 | 1431 | 94 | 15 | 37142655 | |
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 19059502 | ||
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 18357469 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 11689484 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 11689483 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 2476070 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 8.50e-06 | 15 | 94 | 3 | 8838678 | |
| Pubmed | 1.04e-05 | 16 | 94 | 3 | 19259974 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 1.51e-05 | 18 | 94 | 3 | 17097888 | |
| Pubmed | NCOR2 PCYOX1L PIGA CLASP1 BSG MLH1 KIF14 GEMIN5 CPD CLINT1 NUP188 XPO1 DCTN1 | 1.57e-05 | 1168 | 94 | 13 | 19946888 | |
| Pubmed | 1.65e-05 | 56 | 94 | 4 | 37059927 | ||
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 1.80e-05 | 19 | 94 | 3 | 17373692 | |
| Pubmed | 1.84e-05 | 418 | 94 | 8 | 34709266 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | NCOR2 FLNC CLASP1 DSG1 BSG CSPG4 GEMIN5 ZNF205 CPD NUP188 XPO1 ZNF160 MNT | 2.13e-05 | 1203 | 94 | 13 | 29180619 |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 20923852 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19760673 | ||
| Pubmed | Identification of four classes of brain nicotinic receptors using beta2 mutant mice. | 2.16e-05 | 3 | 94 | 2 | 9614223 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 25068303 | ||
| Pubmed | Human lung expresses unique gamma-glutamyl transpeptidase transcripts. | 2.16e-05 | 3 | 94 | 2 | 7689219 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 1397297 | ||
| Pubmed | GREB1L PLXNA3 NCOR2 TMEM94 MLH1 HIPK2 KIF14 DNAAF9 NUP188 MNT DNAH14 FDXACB1 ZNF121 | 2.37e-05 | 1215 | 94 | 13 | 15146197 | |
| Pubmed | 3.28e-05 | 591 | 94 | 9 | 15231748 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MAGI2 NCOR2 FLNC VMAC BSG CSPG4 CPD KIFC3 XPO1 PNPLA7 WLS CTSB TRIP11 MNT | 3.49e-05 | 1451 | 94 | 14 | 30550785 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | GREB1L HIVEP1 ARHGEF28 MLH1 ZNF205 CPD KIFC3 CTSB DCTN1 DHX29 DNAH14 | 4.11e-05 | 925 | 94 | 11 | 28986522 |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 27645992 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 29212715 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 19482438 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 9384599 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 16314871 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 20854418 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 NCOR2 FLNC CELSR1 TMEM94 CSPG4 FLCN GEMIN5 NUP188 KIFC3 DCTN1 GBA2 | 4.33e-05 | 1105 | 94 | 12 | 35748872 |
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 5.34e-05 | 27 | 94 | 3 | 14581517 | |
| Pubmed | 5.34e-05 | 27 | 94 | 3 | 18478268 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 5.83e-05 | 247 | 94 | 6 | 39238192 | |
| Pubmed | 5.92e-05 | 638 | 94 | 9 | 31182584 | ||
| Pubmed | 6.25e-05 | 497 | 94 | 8 | 23414517 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | FBLN1 PDE4D POC1A CLASP1 BSG ANAPC2 KIF14 CLINT1 NUP188 KIFC3 XPO1 DCTN1 | 6.62e-05 | 1155 | 94 | 12 | 20360068 |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 6.64e-05 | 29 | 94 | 3 | 22424930 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 1682866 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 25031416 | ||
| Pubmed | Blood and lymphatic systems are segregated by the FLCN tumor suppressor. | 7.19e-05 | 5 | 94 | 2 | 33298956 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 15778499 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 26954557 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 15489024 | ||
| Pubmed | The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. | 7.19e-05 | 5 | 94 | 2 | 17873280 | |
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 1.05e-04 | 275 | 94 | 6 | 20734064 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 16956611 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 15583422 | ||
| Pubmed | Ankyrin-B regulates Kir6.2 membrane expression and function in heart. | 1.08e-04 | 6 | 94 | 2 | 20610380 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 15922075 | ||
| Pubmed | 1.32e-04 | 95 | 94 | 4 | 20843830 | ||
| Pubmed | Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. | 1.50e-04 | 7 | 94 | 2 | 8393145 | |
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 1315305 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 9009220 | ||
| Cytoband | 2p13 | 1.02e-03 | 23 | 94 | 2 | 2p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.28e-03 | 797 | 94 | 7 | chr19p13 | |
| Cytoband | 19p13.3 | 1.47e-03 | 237 | 94 | 4 | 19p13.3 | |
| Cytoband | 19q13.11 | 3.88e-03 | 45 | 94 | 2 | 19q13.11 | |
| Cytoband | 18q11.2 | 4.22e-03 | 47 | 94 | 2 | 18q11.2 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 1.35e-05 | 13 | 67 | 3 | 564 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.63e-05 | 16 | 67 | 3 | 173 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.79e-04 | 9 | 67 | 2 | 1234 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.59e-04 | 46 | 67 | 3 | 622 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.27e-03 | 718 | 67 | 9 | 28 | |
| GeneFamily | Olfactory receptors, family 4 | 1.34e-03 | 129 | 67 | 4 | 151 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-06 | 200 | 94 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.30e-06 | 133 | 94 | 5 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-05 | 168 | 94 | 5 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 168 | 94 | 5 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 168 | 94 | 5 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 169 | 94 | 5 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.58e-05 | 176 | 94 | 5 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.58e-05 | 176 | 94 | 5 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.68e-05 | 177 | 94 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.20e-05 | 182 | 94 | 5 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.91e-05 | 188 | 94 | 5 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 193 | 94 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-05 | 193 | 94 | 5 | 9f798a1bbd9f076c3122d02ed28418c18bb7a369 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-05 | 194 | 94 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.83e-05 | 195 | 94 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.83e-05 | 195 | 94 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 195 | 94 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.83e-05 | 195 | 94 | 5 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 195 | 94 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 196 | 94 | 5 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 6.12e-05 | 197 | 94 | 5 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.27e-05 | 198 | 94 | 5 | 85881637641d8996be2edc65c4bceff0433135e7 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 6.42e-05 | 199 | 94 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.42e-05 | 199 | 94 | 5 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.74e-05 | 103 | 94 | 4 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 7.56e-05 | 206 | 94 | 5 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| Drug | tetramethylammonium | 2.64e-06 | 53 | 94 | 5 | CID000006380 | |
| Drug | Ultracet | 6.78e-06 | 64 | 94 | 5 | CID000005523 | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 2277_UP | |
| Drug | (-)-pictamine | 2.99e-05 | 15 | 94 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 2.99e-05 | 15 | 94 | 3 | CID006918624 | |
| Drug | UB-165 | 2.99e-05 | 15 | 94 | 3 | CID004694339 | |
| Drug | AC1L2SVN | 3.67e-05 | 16 | 94 | 3 | CID000127922 | |
| Drug | fluoxetine | 4.14e-05 | 225 | 94 | 7 | CID000003386 | |
| Drug | ABT-594 | 5.32e-05 | 18 | 94 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 5.32e-05 | 18 | 94 | 3 | CID000656712 | |
| Drug | AC1L9P88 | 6.29e-05 | 19 | 94 | 3 | CID000450860 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 6.29e-05 | 19 | 94 | 3 | CID000162425 | |
| Drug | isoarecolone | 6.29e-05 | 19 | 94 | 3 | CID000146970 | |
| Drug | beta-erythroidine | 6.29e-05 | 19 | 94 | 3 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 6.29e-05 | 19 | 94 | 3 | CID000107881 | |
| Drug | 5-fluoro-8-hydroxy-2-(dipropylamino)tetralin | 7.38e-05 | 20 | 94 | 3 | CID000005122 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 7.38e-05 | 20 | 94 | 3 | CID000001962 | |
| Drug | dinotefuran | 8.59e-05 | 21 | 94 | 3 | CID000197701 | |
| Drug | meproadifen | 8.59e-05 | 21 | 94 | 3 | CID000189752 | |
| Drug | AR-R17779 | 9.91e-05 | 22 | 94 | 3 | CID005310971 | |
| Drug | histrionicotoxin | 9.91e-05 | 22 | 94 | 3 | CID005282247 | |
| Drug | clothianidin | 9.91e-05 | 22 | 94 | 3 | CID000213027 | |
| Drug | AC1N6PQL | 1.01e-04 | 4 | 94 | 2 | CID004263851 | |
| Drug | AC1L3BL8 | 1.14e-04 | 23 | 94 | 3 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 1.14e-04 | 23 | 94 | 3 | CID000133011 | |
| Drug | alpha-conotoxin SI | 1.14e-04 | 23 | 94 | 3 | CID000163979 | |
| Drug | CID6325740 | 1.14e-04 | 23 | 94 | 3 | CID006325740 | |
| Drug | ABT-418 | 1.14e-04 | 23 | 94 | 3 | CID000119380 | |
| Drug | Skpymrfamide | 1.14e-04 | 23 | 94 | 3 | CID000132661 | |
| Drug | procyclidine | 1.30e-04 | 24 | 94 | 3 | CID000004919 | |
| Drug | anabaseine | 1.30e-04 | 24 | 94 | 3 | CID000018985 | |
| Drug | intruder | 1.30e-04 | 24 | 94 | 3 | CID000213021 | |
| Drug | Nortryptoquivaline | 1.35e-04 | 63 | 94 | 4 | CID000324966 | |
| Drug | anabasine | 1.47e-04 | 25 | 94 | 3 | CID000002181 | |
| Drug | varenicline | 1.47e-04 | 25 | 94 | 3 | CID000170361 | |
| Drug | pempidine | 1.47e-04 | 25 | 94 | 3 | CID000006603 | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 3508_DN | |
| Drug | benzquinamide | 1.65e-04 | 26 | 94 | 3 | CID000002342 | |
| Drug | beta-eudesmol | 1.65e-04 | 26 | 94 | 3 | CID000091457 | |
| Drug | curarine | 1.65e-04 | 26 | 94 | 3 | CID000198004 | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5252_UP | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 4737_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; HL60; HG-U133A | 1.68e-04 | 197 | 94 | 6 | 1789_DN | |
| Drug | HA-1077 dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.73e-04 | 198 | 94 | 6 | 343_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4392_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 7211_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 2498_UP | |
| Drug | azathioprine, USP; Down 200; 100uM; MCF7; HG-U133A | 1.83e-04 | 200 | 94 | 6 | 338_DN | |
| Drug | scopolamine | 1.83e-04 | 200 | 94 | 6 | CID000005184 | |
| Drug | methylcarbamylcholine | 1.86e-04 | 27 | 94 | 3 | CID000004136 | |
| Drug | nornicotine | 1.86e-04 | 27 | 94 | 3 | CID000000412 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 9.52e-07 | 7 | 90 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.52e-06 | 8 | 90 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.49e-05 | 16 | 90 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Milroy Disease | 9.15e-05 | 5 | 90 | 2 | C1704423 | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 1.37e-04 | 6 | 90 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | pneumococcal meningitis | 2.55e-04 | 8 | 90 | 2 | EFO_1001114 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.55e-04 | 8 | 90 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 5.95e-04 | 616 | 90 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.95e-04 | 616 | 90 | 8 | C0376358 | |
| Disease | N-acetylmethionine measurement | 9.41e-04 | 15 | 90 | 2 | EFO_0021427 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.11e-03 | 148 | 90 | 4 | C0279702 | |
| Disease | cerebral infarction (is_marker_for) | 1.52e-03 | 19 | 90 | 2 | DOID:3526 (is_marker_for) | |
| Disease | sphingomyelin 24:1 measurement | 2.23e-03 | 23 | 90 | 2 | EFO_0010398 | |
| Disease | West Syndrome | 2.43e-03 | 24 | 90 | 2 | C0037769 | |
| Disease | venous thromboembolism | 2.87e-03 | 460 | 90 | 6 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIVTVFVINVHHRSS | 311 | Q05901 | |
| HHIQIASTAIKVTET | 196 | Q76B58 | |
| EHILQSTFVHVISSN | 16 | P41595 | |
| VSAEAVTTTLHQVTR | 256 | Q9UJX6 | |
| ICIHTNAHVSVEVSA | 121 | P07858 | |
| EVSVHINAHRLEISV | 286 | Q6UVK1 | |
| QLSTHTHVVDITRTS | 1161 | Q14203 | |
| LTAVTSQHIEIHEGT | 156 | Q9Y6D6 | |
| TTRTFTIHAVSREHE | 211 | Q6UY09 | |
| RHIQVANHVISSDSI | 3846 | Q8TCU4 | |
| DGTRSHTAHVLINVT | 766 | Q9NYQ6 | |
| VSHVIVDEVHERSVQ | 696 | Q7Z478 | |
| IHQSLVESSHRVEVL | 71 | Q9UHL0 | |
| RSNHVSRTEVSSNHV | 1401 | P01023 | |
| TRVVQFFHTLLHTVS | 411 | Q149M9 | |
| IHNEETHTTSITQVL | 801 | Q09MP3 | |
| VVGLSLVHTVAHTVN | 321 | Q96PH1 | |
| HERIITVSTNGSIHS | 46 | Q9NRA1 | |
| ITVIVINTHHRSPST | 311 | P02708 | |
| TQSHSDLVRTSEHQV | 1596 | Q8N1W1 | |
| HHTQIASTFIAVVQA | 531 | A6NGU5 | |
| VETHSTVTQRFSHSE | 8226 | Q8WXI7 | |
| HQRVVTLAQHISEVI | 2126 | Q9Y618 | |
| STVFRAHTATVRSVH | 96 | Q8NBT0 | |
| SRVTHIVHQELESLA | 1561 | Q15058 | |
| VATHTSVQHATVIPE | 726 | Q9H2X6 | |
| FASHSLQTSDVVIHR | 911 | Q86UL8 | |
| TVTTKHIHITQATET | 256 | Q14677 | |
| HIHITQATETTTTRH | 261 | Q14677 | |
| AETIRFSQHAVVASH | 176 | P78508 | |
| AVIVEVHAAARSTLH | 436 | Q8NFG4 | |
| GRVAQTHVAVLESHT | 566 | Q5VTL7 | |
| EVHLIARHVTTSVVT | 3441 | Q5CZC0 | |
| VIHATVTSVTLHSTE | 261 | Q8NBM8 | |
| FVVTDTTLTHLAVHR | 26 | P51805 | |
| LLIVITVVSDSHLHS | 36 | Q8NH21 | |
| HAADVVQSTHVLLST | 466 | Q08499 | |
| RHHHTQITSTFIAVV | 186 | Q9BX51 | |
| HSLHETSTVLVETVT | 2601 | Q14315 | |
| IAHTATTHASVIQTV | 441 | Q99583 | |
| TTHASVIQTVNHVLQ | 446 | Q99583 | |
| HHTQIASTFIAVVQA | 181 | Q14390 | |
| LLIVITVVSDSHLHS | 36 | Q8NGA8 | |
| RHEALSTCVSHITVV | 231 | Q8NGP0 | |
| VLVHDNSHVELTSVI | 776 | Q9C091 | |
| HVSALTLTAIAVDRH | 156 | Q9NYM4 | |
| TVEVSIHNRLQTSQH | 1036 | Q9UPP2 | |
| IHHPRESSNVVVTER | 911 | Q02413 | |
| VVETLTHQARATTVH | 646 | Q6ZV29 | |
| THQARATTVHAVRDS | 651 | Q6ZV29 | |
| VSHRNVVNVHIFVSE | 686 | P23142 | |
| AVAARVTAATTVTHI | 336 | Q9HCG7 | |
| LATVHVTTVVHKTST | 1356 | P01031 | |
| HQHAASTISIDTLVE | 86 | P35613 | |
| SQVFVHHDAASSVVI | 1271 | O75976 | |
| VSNVVFTSHTTEQRH | 886 | Q5TEA3 | |
| VDALTFTHHVISNTT | 3351 | Q0VDD8 | |
| STTVRVHRSSAQNVH | 131 | O75449 | |
| HTVARAVSQDTIISI | 556 | Q9BRP7 | |
| VVSTHTVQHLEEVDL | 36 | O75363 | |
| AEATHRVITIANRTH | 226 | Q9BPU6 | |
| NADRESHTHVSVVIS | 296 | Q9HAU5 | |
| LLIVITVVSDSHLHS | 36 | Q96R69 | |
| NEHSSRSHALLIVTV | 641 | Q9BVG8 | |
| VHADSSRSHLIITVT | 191 | Q9UIL4 | |
| SISHVAHVTITTKTA | 106 | P40692 | |
| SIVTSVCVLNVHHRS | 311 | P17787 | |
| TVVTIAHRVHTILSA | 1531 | Q09428 | |
| QTHSLERHISVLAET | 476 | Q7Z460 | |
| VRSSLTTHQAIHTGE | 441 | Q9H7R5 | |
| IFVRERVTIIHSHSS | 116 | P37287 | |
| DILQHIFSVVTDTSH | 921 | O14980 | |
| FSVRSSLAIHQTIHT | 406 | Q9HCG1 | |
| AENITTVSVIKDHHT | 216 | Q6ZMY6 | |
| TVSVIKDHHTRSITS | 221 | Q6ZMY6 | |
| ESSQVRAHTLSQHAV | 991 | Q9C0A1 | |
| TRRVHITHEVSSLDT | 191 | Q9C0H9 | |
| VVHHQDTETSVIFDI | 276 | Q96DM3 | |
| VLHTVFISITHVHRT | 1241 | Q12767 | |
| VNETEGSSRTRHHVT | 256 | Q9NVW2 | |
| QTHTELSSILTIHNV | 286 | P35916 | |
| VVTEHALHQHTISTL | 101 | Q8TEQ6 | |
| HVVSTADVIQHCQRV | 551 | Q5SRE5 | |
| RQSVLTGHTDIVTHV | 771 | P08922 | |
| QTIIHATHSVATAAQ | 1041 | O15040 | |
| HITSRSQEELEAHVV | 161 | Q8TCN5 | |
| FTVSSHLVEHVRIHT | 181 | P58317 | |
| FATSSQLIEHIRTHT | 321 | P58317 | |
| QSSALVTHQRTHTGV | 431 | O95201 | |
| LHARISSTSHTQDVV | 1071 | Q15643 | |
| SSTFREHVRIHTQEQ | 376 | Q68EA5 | |
| HSGEELQLTTTITHV | 511 | Q5T9L3 | |
| SEATVHSLQATVHQR | 76 | Q2NL98 | |
| FTGRSSLIVHQIVHT | 391 | Q9NQZ8 | |
| VSVVHRTLGTHRNTV | 2431 | P15822 | |
| TSTFTVTAHRAQHEL | 91 | Q86YD3 | |
| LHHVTFTSATLVVII | 301 | Q5R3F8 | |
| VTVSLLFSHVDHVIA | 21 | P32418 | |
| HNLHSLTSIVDSITV | 196 | P15173 |